T cells: TNF and Death Receptors

Tumor necrosis factor alpha (TNFa) is an important signaling molecule throughout the immune system. Recent work has focused on the differences in expression and signaling pathways (inflammation vs. tissue regeneration) mediated by TNF receptor 1 (TNFR1) and TNFR2 and the potential for targeting one subtype over the other for therapeutic interventions. Find the latest research on T cells and TNF receptors here.

July 3, 2020
Open Access

New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis

Iñaki EtxeberriaIgnacio Melero
July 3, 2020
Open Access

Immunomodulation of NK Cells by Ionizing Radiation

Frontiers in Oncology
Jiarui ChenConghua Xie
July 24, 2020

Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesis

Journal of Cellular Physiology
You-Jin JoWoojin Jeong
August 19, 2020
Open Access

Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs

JCI Insight
Judith WienkeFemke van Wijk
August 28, 2020

Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8+ T Cell Development

The Journal of Immunology : Official Journal of the American Association of Immunologists
Mohammad Farhad AmaniWilliam L Redmond
May 27, 2020
Open Access

HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo

Molecular Therapy : the Journal of the American Society of Gene Therapy
Colby R MaldiniJames L Riley
May 26, 2020

TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models

Journal of Leukocyte Biology
Katherine CaseDenise L Faustman
July 27, 2020
Open Access

Bilateral Sensorineural Hearing Loss Associated With Nivolumab Therapy for Stage IV Malignant Melanoma

Ear, Nose, & Throat Journal
Alex J F TampioBrian D Nicholas
September 20, 2020

Psoriasis and Antimicrobial Peptides

International Journal of Molecular Sciences
Toshiya Takahashi, Kenshi Yamasaki
June 7, 2020
Open Access

Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke

Acta Neuropathologica Communications
Bettina H ClausenKate L Lambertsen
May 29, 2020

CD8+ GITR+ T cells may negatively regulate T cell overactivation in aplastic anemia

Immunological Investigations
Guixuan HuangBo Li
September 8, 2020

Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET

European Review for Medical and Pharmacological Sciences
B S KimY H Kim
May 27, 2020
Open Access

The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA

Disease Markers
Chengquan ShenYonghua Wang

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2020 Meta ULC. All rights reserved